Insights

Strategic Partnerships Manufacturing agreement with Cyanotech to grow and process ZIVO's proprietary algal biomass creates a scalable supply chain and contract manufacturing opportunity for the Zivolife product line, opening doors for algae-based co development and OEM partnerships.

Animal Health Collaboration University of Delaware collaboration to combat Avian Influenza in poultry signals sales potential for veterinary health products, feed additives, or research services built on ZIVO's algal and microbial platform.

IP Licensing A diverse portfolio of proprietary algal and bacterial strains, biologically active molecules, and cultivation techniques offers licensing or joint development opportunities across human and animal health markets.

Contract Development ZIVO's R&D focus and production knowhow enable contract development and process optimization services for biotechs seeking algae-based production capabilities and scalable manufacturing workflows.

US-Based Partner A lean Michigan based team with cloud enabled infrastructure positions ZIVO as a nimble, domestically focused partner for mid market biotech and nutraceutical companies pursuing rapid collaboration and pilots.

Similar companies to ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc. Tech Stack

ZIVO Bioscience, Inc. uses 8 technology products and services including Amazon Web Services, RSS, Google Fonts API, and more. Explore ZIVO Bioscience, Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • RSS
    Content Management System
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Search Console
    Web Analytics
  • GoDaddy
    Web Hosting
  • Apache
    Web Servers
  • prettyPhoto
    Web Tools And Plugins

Media & News

ZIVO Bioscience, Inc.'s Email Address Formats

ZIVO Bioscience, Inc. uses at least 1 format(s):
ZIVO Bioscience, Inc. Email FormatsExamplePercentage
FLast@zivobioscience.comJDoe@zivobioscience.com
83%
First@zivobioscience.comJohn@zivobioscience.com
17%

Frequently Asked Questions

What is ZIVO Bioscience, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ZIVO Bioscience, Inc.'s official website is zivobioscience.com and has social profiles on LinkedInCrunchbase.

What is ZIVO Bioscience, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
ZIVO Bioscience, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ZIVO Bioscience, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, ZIVO Bioscience, Inc. has approximately 8 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Research Development: W. P.. Explore ZIVO Bioscience, Inc.'s employee directory with LeadIQ.

What industry does ZIVO Bioscience, Inc. belong to?

Minus sign iconPlus sign icon
ZIVO Bioscience, Inc. operates in the Biotechnology Research industry.

What technology does ZIVO Bioscience, Inc. use?

Minus sign iconPlus sign icon
ZIVO Bioscience, Inc.'s tech stack includes Amazon Web ServicesRSSGoogle Fonts APIjQueryGoogle Search ConsoleGoDaddyApacheprettyPhoto.

What is ZIVO Bioscience, Inc.'s email format?

Minus sign iconPlus sign icon
ZIVO Bioscience, Inc.'s email format typically follows the pattern of FLast@zivobioscience.com. Find more ZIVO Bioscience, Inc. email formats with LeadIQ.

How much funding has ZIVO Bioscience, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, ZIVO Bioscience, Inc. has raised $24M in funding. The last funding round occurred on Apr 05, 2023 for $1M.
ZIVO Bioscience, Inc. logo

ZIVO Bioscience, Inc.

Biotechnology ResearchMichigan, United States2-10 Employees

ZIVO Bioscience, Inc. is a biotechnology research and development company listed on the OTCQB and based in Troy, Michigan, with a small workforce of 2 to 10 employees. The company maintains an intellectual property portfolio that includes proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. ZIVO focuses on developing product candidates derived from proprietary algal cultures for potential use in human and animal health, including therapeutic, medicinal, and nutritional applications. In April 2026, ZIVO signed a manufacturing agreement with Cyanotech Corporation to grow, cultivate, and process its proprietary algal biomass for the Zivolife product line. The company has engaged in partnerships and corporate actions, such as a 2025 collaboration with the University of Delaware to study Avian Influenza in poultry, a 2023 reverse stock split, and leadership changes in 2022 with John B. Payne appointed as President and CEO.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $24M

    ZIVO Bioscience, Inc. has raised a total of $24M of funding over 15 rounds. Their latest funding round was raised on Apr 05, 2023 in the amount of $1Mas a post_ipo_debt.

  • $1M$10M

    ZIVO Bioscience, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $24M

    ZIVO Bioscience, Inc. has raised a total of $24M of funding over 15 rounds. Their latest funding round was raised on Apr 05, 2023 in the amount of $1Mas a post_ipo_debt.

  • $1M$10M

    ZIVO Bioscience, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.